Proton therapy

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024
ASG, Proton, MgB2, Proton therapy, University, MRI, Heart, Radiation, Magnet, Pelvis, Map, Abdomen, Neoplasm, Movement, Radiation Research, Magnetic resonance imaging, Medical imaging

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

Kansas City Proton Institute Begins Cancer Treatments with Advanced MEVION S250i Proton Therapy System

Retrieved on: 
Friday, December 22, 2023
Oncology, Medical Devices, Health, Hospitals, Surgery, Radiology, Proton, Liver, Intensity, Proton therapy, Risk, Multimedia, Stomach, Physician, Lung, Breast, Spinal cord, KCPI, Brain, Doctor of Philosophy, MLC, Motion, Head, 3D, Neoplasm, Prostate, Esophagus, Patient, Radiation, Neck, Skin, Medical imaging

Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System® .

Key Points: 
  • Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System® .
  • (Photo: Business Wire)
    Kansas City Proton Institute recently opened the doors to its new facility that houses the region’s first Mevion compact proton therapy system.
  • The MEVION S250i system at KCPI also integrates an advanced 3D imaging system and will install the C-RAD Catalyst PT surface-guided tracking system, enabling a cutting-edge Image-Guided Proton Therapy configuration for high-precision patient positioning and intra-fraction motion management.
  • “We congratulate Kansas City Proton Institute for starting treatment with the Mevion proton therapy system,” said Tina Yu, PhD, chief executive officer and president of Mevion Medical Systems.

American Shared Hospital Services Reports Third Quarter 2023 Financial Results

Retrieved on: 
Monday, November 13, 2023
Proton, AMS, EBITDA, Three Months, NYSE, Proton therapy, SAN, ASTRO, Investment, Orlando Health, Marketing, Webcast, Marine Hospital Service, MD Anderson Cancer Center, Conference, Cancer, Growth, Original equipment manufacturer, Nine Months, LINAC, Society, Overalls, Pharmaceutical industry, Video game, Cryptocurrency, Clothing, Lithium, Life insurance, Esprit, Radiosurgery, Neuroscience

SAN FRANCISCO, CA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Operating income for the third quarter of 2023 was $90,000 compared to operating income of $448,000 in the third quarter of 2022.
  • Adjusted EBITDA, a non-GAAP financial measure, was $1,669,000 for the third quarter of 2023, compared to $1,966,000 for the third quarter of 2022.
  • Net income attributable to American Shared Hospital Services in the third quarter of 2023 was $118,000, or $0.02 per diluted share, compared to net income of $316,000, or $0.05 per diluted share, for the third quarter of 2022.
  • Adjusted EBITDA, a non-GAAP financial measure, was $1,669,000 for the third quarter of 2023, compared to $1,966,000 for the third quarter of 2022.

Atrium Health Levine Cancer Welcomes Arrival of Cutting-Edge Accelerator for Revolutionary Proton Therapy

Retrieved on: 
Monday, December 11, 2023
Oncology, Medical Devices, Health, Hospitals, Health Technology, Radiology, Brain, Radiation, Atrium Health, Patient, Multimedia, Neoplasm, Hospital, Quality of life, Life, Travel, Proton therapy, Medical imaging, Proton, Carolinas

Weighing in at 15 tons, this crucial piece of equipment will serve as the powerhouse for proton beam therapy at the Atrium Health Levine Cancer Proton & Advanced Radiation Center , upon completion of installation next year.

Key Points: 
  • Weighing in at 15 tons, this crucial piece of equipment will serve as the powerhouse for proton beam therapy at the Atrium Health Levine Cancer Proton & Advanced Radiation Center , upon completion of installation next year.
  • View the full release here: https://www.businesswire.com/news/home/20231211377498/en/
    MEVION S250i Proton Accelerator Delivery at Atrium Health Levine Cancer (Photo: Business Wire)
    Proton beam therapy targets radiation precisely to a tumor, leaving the areas around it unharmed.
  • “This is one of the final steps in completing the Atrium Health Levine Cancer Proton and Advanced Radiation Center,” said Dr. Ruben Mesa , president of Atrium Health Levine Cancer.
  • When all services are available to patients, the Atrium Health Levine Cancer Proton and Advanced Radiation Center will be the only location offering proton therapy treatments between Washington, D.C., and Atlanta, and one of just 44 proton beam therapy sites in the country.

Siteman Cancer Center Begins Treatment with Latest Mevion Proton Therapy System

Retrieved on: 
Thursday, November 16, 2023
Research, Hospitals, Health Technology, Radiology, Health, University, Science, Education, Oncology, Proton, Lung, Neck, NCI-designated Cancer Center, Brain, Radiation, Proton therapy, Head, Barnes-Jewish Hospital, Risk, FLASH, Intensity, Hospital, Scan (company), Varian Medical Systems, Breast cancer, NCI, Patient, Multimedia, Heart, IGRT, Image-guided radiation therapy, Metal toxicity, MLC, 3D, Professor, Medical imaging, Pharmaceutical industry

Mevion Medical Systems announced today that the world’s first single-room proton therapy system has completed the upgrade to the latest MEVION S250i Proton Therapy System® with FLASH* capabilities, and has begun treating patients in November at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO.

Key Points: 
  • Mevion Medical Systems announced today that the world’s first single-room proton therapy system has completed the upgrade to the latest MEVION S250i Proton Therapy System® with FLASH* capabilities, and has begun treating patients in November at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO.
  • View the full release here: https://www.businesswire.com/news/home/20231116635095/en/
    The MEVION S250i Proton Therapy System (Photo: Business Wire)
    Siteman Cancer Center is an NCI-designated Comprehensive Cancer Center that draws patients from Missouri, Southern Illinois and beyond.
  • “Our team also looks forward to advancing FLASH dosimetry research.”
    This latest system incorporates Mevion's cutting-edge HYPERSCAN® Pencil Beam Scanning for Intensity Modulated Proton Therapy (IMPT) with a proton MLC, along with an advanced 3D imaging system for high-precision Image-Guided Radiation Therapy (IGRT) and adaptive therapy.
  • These latest capabilities are the result of a collaborative effort between Mevion and Siteman Cancer Center, initiated in 2019.

ProCure Doctors Urge Cancer Screenings as a Priority in the New Year

Retrieved on: 
Wednesday, December 13, 2023
Proton, Health, Patient, Radiation, Procurement, Cancer, COVID, Survival, Proton therapy, Medical imaging

SOMERSET, N.J., Dec. 13, 2023 /PRNewswire/ -- If you pledge to make your health a priority in 2024, one New Year's resolution should be to make cancer screenings a top priority, said Dr. Brian Chon, medical director of ProCure Proton Therapy Center.

Key Points: 
  • SOMERSET, N.J., Dec. 13, 2023 /PRNewswire/ -- If you pledge to make your health a priority in 2024, one New Year's resolution should be to make cancer screenings a top priority, said Dr. Brian Chon, medical director of ProCure Proton Therapy Center.
  • However, due to COVID, many people have delayed or skipped their routine screenings , which could lead to missed or late diagnoses and worse outcomes.
  • Early detection of cancer also enables patients to explore advanced treatment options, such as proton therapy.
  • With laser-like accuracy, proton therapy precisely targets cancer while sparing surrounding healthy tissue, often with fewer side effects and less downtime .

Premier Breast Health Institute Opens State-of-the-Art Facility

Retrieved on: 
Wednesday, November 15, 2023
Proton, Woman, City, Risk, Clinical research, Breast cancer, Breast ultrasound, Patient, Mammography, Medicine, FACS, Genetic testing, United Surgical Partners International, Oncology, Diagnosis, MRI, Knowledge, Proton therapy, Education, Birth control, Nursing, Medical imaging, MD

OKLAHOMA CITY, Nov. 15, 2023 /PRNewswire-PRWeb/ -- In a remarkable milestone for breast health care, Premier Breast Health Institute is excited to announce the opening of their brand-new, 25,000-square-foot facility in Oklahoma City. This state-of-the-art institute marks a significant step forward in providing unparalleled breast health services, offering women in our community access to innovative technology and personalized care under one roof.

Key Points: 
  • Premier Breast Health Institute of Oklahoma, a pioneer in breast health care, announces the grand opening of their cutting-edge facility, revolutionizing breast screenings in Oklahoma.
  • OKLAHOMA CITY, Nov. 15, 2023 /PRNewswire-PRWeb/ -- In a remarkable milestone for breast health care, Premier Breast Health Institute is excited to announce the opening of their brand-new, 25,000-square-foot facility in Oklahoma City.
  • "I am thrilled to announce the opening of Premier Breast Health Institute, a culmination of my long-term dream, says Stephanie L. Taylor, MD, FACS, Surgical Partners of Oklahoma.
  • Premier Breast Health Institute is located in south Oklahoma City at 8516 S. Portland Avenue, Oklahoma City, OK 73159.

Mevion Selected to Equip BayCare’s Proton Therapy Center in Tampa

Retrieved on: 
Friday, November 3, 2023
Medical Devices, Hospitals, Health, Radiology, Oncology, Proton, Science, IGRT, Center of excellence, Laboratory, Central Florida, Heart, Varian Medical Systems, FLASH, Winter Haven Hospital, Cancer Institute, DECT, FIT, Franciscan Sisters of Allegany, Internal medicine, Hospital, Proton therapy, MLC, CT, Stroke, Neurosurgery, Fred J. Ansfield, Franciscan Sisters, Cancer, ARC, BayCare Ballpark, Patient, Intensity, Scan (company), Morton Plant Hospital, Medical imaging, Nursing, Tampa Bay

Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, is pleased to announce it has been selected by BayCare to equip the St. Joseph’s Hospital Cancer Institute in Tampa with a MEVION S250-FIT Proton Therapy System™*.

Key Points: 
  • Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, is pleased to announce it has been selected by BayCare to equip the St. Joseph’s Hospital Cancer Institute in Tampa with a MEVION S250-FIT Proton Therapy System™*.
  • “BayCare is bringing an advanced proton radiation therapy center to Tampa so patients in our community don’t have to drive to Orlando or beyond to get this level of high-quality care.”
    The MEVION S250-FIT Proton Therapy System is thoughtfully designed to expedite proton therapy project timelines with a compact footprint, reduced construction requirements, and accelerated installation process.
  • “We are dedicated to advancing proton therapy technology and access, and I look forward to making a meaningful difference to patients and families across West Central Florida.”
    *The MEVION S250-FIT Proton Therapy System, FLASH therapy, online adaptive therapy, and ARC therapy are not yet available for clinical use.
  • Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy.

St. Joseph's Hospital to Open First Proton Radiation Therapy Center in Tampa Bay Area

Retrieved on: 
Friday, November 3, 2023
Radiation, Proton therapy, X-ray, St. Joseph's Hospital, Winter Haven Hospital, Research, Tissue, Risk, Hospital, Fred J. Ansfield, Secondary malignant neoplasm, St. Joseph's Hospital (St. Paul, Minnesota), Cancer, BayCare Ballpark, Patient, Morton Plant Hospital, Medical imaging, Tampa Bay, Proton, Saint Joseph's

TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ -- Construction of the first proton therapy center to open in the Tampa Bay area is set to begin at St. Joseph's Hospital Cancer Institute, bringing technologically advanced treatment closer to home for local cancer patients.

Key Points: 
  • TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ -- Construction of the first proton therapy center to open in the Tampa Bay area is set to begin at St. Joseph's Hospital Cancer Institute , bringing technologically advanced treatment closer to home for local cancer patients.
  • "BayCare is bringing the first proton radiation therapy center to Tampa so patients in our community don't have to drive to Orlando or beyond to get this level of high-quality care."
  • Woods Radiation Therapy Center and proton therapy treatment is expected to be available by fall 2025.
  • Woods Radiation Therapy Center at St. Joseph's Hospital treats more than 900 patients each year using a variety of radiation therapy treatments and state-of-the-art equipment.

NFL HEAD COACH PLEDGES TO PAY FORWARD SUPPORT HE RECEIVED WHEN FACING CANCER DIAGNOSIS

Retrieved on: 
Friday, October 20, 2023
Proton, Commander, Cancer Moonshot, Pancreatic cancer, Insurance, NFL, Policy, Education, Love, Survivor, Pancreatic Cancer Action Network, White House, Aladdin, Family, Carcinoma, Human, Organization, CSC, Research, BeiGene, Tsuchizaki Shinmeisha Shrine Annual Celebration And The Float Festival, Hay–Adams Hotel, Rivera, Medicine, ESPN, Caregiver, Recurrence, Proton therapy, White, Founder's Award, Cancer, Public service, Patient, Diagnosis, Cancer Support Community, National Association, Music, Nursing, Pharmaceutical industry

He continued to coach throughout his treatments and, in January 2021, he was declared cancer-free.

Key Points: 
  • He continued to coach throughout his treatments and, in January 2021, he was declared cancer-free.
  • Coach Rivera’s reflections are in line with the Cancer Support Community’s (CSC) experience serving hundreds of thousands of people impacted by cancer across the United States and beyond.
  • “I have been cancer-free since 2021 and now it’s my turn to pay it forward,” Coach Rivera explained in pre-recorded acceptance remarks, due to the Commanders playing schedule.
  • Coach Rivera’s dedication to supporting people facing a cancer diagnosis is just one of the reasons he was honored with the 2023 Founders Award for Spirit at CSC’s Annual Celebration.